Journal profile · Dentistry-Dentistry (miscellaneous)
EJC Paediatric Oncology
ISSN 2772-610X · Elsevier · United Kingdom
EJC Paediatric Oncology: impact factor 2 (journal website); fully open access; APC about USD 2,390; review about 107 days (submission to acceptance, publisher); 211 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
EJC Paediatric Oncology is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Childhood Cancer Survivors' Quality of Life, Neuroblastoma Research and Treatments and Acute Lymphoblastic Leukemia research, together about 39.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
EJC: Paediatric Oncology is a new international, peer reviewed, online-only Gold Open Access journal and the Official Journal of the SIOP EUROPE: THE EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY. The journal is a companion title to the highly respected European Journal of Cancer .The journal focuses on all aspects of paediatric oncology. The journal solicits submissions, special issue suggestions and commentaries on the below topic areas (not exhaustive).Epidemiology includingIncidence / RegistriesRadiologyPathology and genomicsHaemato-Oncology includingALLAML/MDSLymphomaOther haemato-oncological malignanciesSolid tumors includingNeuroblastomaSarcomas (soft tissue and bone sarcomas)Renal tumorsLiver tumorsGerm cell tumorsRare solid tumorsNeuro-Oncology includingGliomasMedulloblastomaEpendymomasDIPGOther central nervous tumorsChemotherapyRadiotherapy including Nuclear MedicineSurgeryImmunotherapyStem cell transplantationEarly clinical trialsLate effects, toxicity and supportive careAYAPsycho-OncologyRegulatory ScienceTumour Pre-disposition
From the journal's Aims & Scope
Research area (LetPub): Dentistry-Dentistry (miscellaneous)
Editor-in-chief Rob PietersPublisher website
Editorial board by country: none in mainland China; most named Germany 11, Netherlands 10, United Kingdom 7, France 4, Italy 4 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Childhood Cancer Survivors' Quality of LifeMedicine15.4%
- Neuroblastoma Research and TreatmentsMedicine13.5%
- Acute Lymphoblastic Leukemia researchMedicine10.4%
- Acute Myeloid Leukemia ResearchMedicine6.3%
- Glioma Diagnosis and TreatmentMedicine4.6%
- Chronic Myeloid Leukemia TreatmentsMedicine3.8%
- Sarcoma Diagnosis and TreatmentMedicine3.5%
- Neutropenia and Cancer InfectionsMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher)
- 2.2Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 1.19LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 1.23OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 99.42%LetPub ·
Volume
- Articles per year
- 53LetPub ·
Articles by year OpenAlex count · 540 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 124 | 124 | 3 |
| 2025 | 211 | 211 | 135 |
| 2024 | 68 | 68 | 358 |
| 2023 | 135 | 135 | 328 |
| 2022 | 2 | 2 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 3 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Figures by source
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 9 daysPublisher website ·
- First decision after review
- 44 daysPublisher website ·
- Submission to acceptance
- 107 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,390 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,340 / EUR 2,190 / GBP 1,870 / JPY 290,230 | — | — | |
| LetPub | USD 2,200 | Yes | — | |
| Publisher website | USD 2,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted16, with length limits
- correspondence5. CorrespondenceLength not stated
- current perspectives3. Current Perspectives (max. 2,000 words)Length not stated
- editorial1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- editorials6. EditorialsLength not stated
- letter1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…main text ≤ 1,000 words
- meta-analysis1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- original research1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- original research article1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- perspective1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- research article1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- review1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- review article1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- review articles2. Review articles (max. 6,000 words)Length not stated
- short communication1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
- short communications4. Short Communications (max. 1,500 words)Length not stated
- systematic review1. Original Research (max. 4,000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should i…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Gold Open Access journal Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2772-610X
- Society / sponsor
- SIOP EUROPE
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about EJC Paediatric Oncology
What is the impact factor of EJC Paediatric Oncology?
The journal's website gives an impact factor of 2; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.2, h-index 12.
How long does peer review take at EJC Paediatric Oncology?
The publisher reports about 107 days (submission to acceptance); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of EJC Paediatric Oncology based?
Of the 43 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (11), Netherlands (10) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index EJC Paediatric Oncology?
According to LetPub and DOAJ records, EJC Paediatric Oncology is indexed in ESCI, Scopus and DOAJ.
Is EJC Paediatric Oncology open access, and what is the APC?
EJC Paediatric Oncology is a fully open-access journal. APC about USD 2,390.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .